gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · ISPCTechnologyR&D — Physical & Biological Sciences

iSpecimen Inc. Common Stock (ISPC)

$0.7969−5.47%
Close Nov 5, 2026 · split-adjusted
Nov 3, 2026$0.79▼ 97.37% in range
Nov 3, 2025Low $0.79 · High $196.96Nov 3, 2026
What changed · written from our data
As of Nov 5, 2026

iSpecimen closed at $0.80 on Nov 5, down 5.47%, within 0.9% of its 52-week closing low. Volume of 100.5K shares was 0.35× its 20-day average (below normal).

Split-adjusted performance: -27.6% over one month, -84.9% over six months, -96.9% over one year.

In the quarter ended Jun 30, 2026, revenue was $151.94K, down 78.7% from a year earlier, with a net margin of -896.9%.

Short interest was 158.8K shares at the Oct 15 settlement, down 1.4% from the prior report (10.4% of float, 2.0 days to cover).

Market cap$2.0M2.5M shares
Revenue · quarter$151.9K−78.7% YoY
Diluted EPS$-0.98—
P/E · TTM—P/S 4.3×
Net margin-896.9%Gross 45.2%
Dividend yieldNone
52-week range0.79 – 196.96−99.6% from high
Volume100.5K0.35× 20-day avg
Volatility · 60d86.5%Annualised
Short % of float10.4%2.0 days to cover
Net cash$4.4MCash $4.4M
Next earnings—Not scheduled
Split-adjusted performance
1W +0.6%1M −27.6%3M −64.1%6M −84.9%YTD −92.3%1Y −96.9%3Y −99.8%5Y −100.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within R&D — Physical & Biological Sciences

Percentile among 11 companies (100 = best)

6-month momentum10
Revenue growth0
Net margin10
Value (low P/E)—
Size10

Industry medians: 6-month return +47.2%, revenue growth +8.5%, net margin −122.0%, P/E 47.5×.

Short interest

Details →
Shares short158.8K−1.4% vs prior
Days to cover2.0Settled Oct 15
% of float10.4%
Short vol. 10d22.2%of daily volume

Closest peers by size in R&D — Physical & Biological Sciences

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
ISPCiSpecimen$0.7969−5.47%−84.9%−78.7%−896.9%—$2.0M
BIAFbioAffinity Technologies$2.65−9.56%−91.7%+19.0%−222.8%—$1.6MCompare
ONMDOneMedNet$4.31−5.18%−56.0%+88.4%−743.8%—$25.1MCompare
IBACIB Acquisition$10.81−0.46%−0.2%———$54.1MCompare
MXCTMaxCyte$1.34−3.60%+53.8%−14.5%−122.0%—$138.3MCompare
NRCNRC Health$26.34−2.70%+40.6%+11.0%12.3%91.1$559.0MCompare
OABIOmniAb$4.86−6.18%+230.6%+78.3%−393.9%—$708.9MCompare
ABSIAbsci$9.47−9.64%+64.7%−46.4%−10443.4%—$1.63BCompare
CRLCharles River Laboratories International$318.51−2.38%+75.3%−2.7%−0.1%—$15.26BCompare

News about iSpecimen

All news →
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewswire Inc. · Aug 7, 2026NeutralE.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimenGlobeNewswire Inc. · Aug 7, 2026▲ PositiveE.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private PlacementGlobeNewswire Inc. · May 12, 2026▲ PositiveiSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private PlacementGlobeNewswire Inc. · May 9, 2026NeutraliSpecimen Is Trending Overnight — Here's Why ISPC Stock Surged 56% In The After-Hours SessionBenzinga · Apr 10, 2026▲ Positive

Quick answers

What does iSpecimen do?
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites.
What is ISPC's market cap?
$2.01M, based on the Nov 5 close of $0.80.
Does iSpecimen pay a dividend?
No regular cash dividend has been paid in the last year.
How much of ISPC is sold short?
158.8K shares, 10.4% of float, as of Oct 15, 2026.
What sector is ISPC in?
Technology, in the R&D — Physical & Biological Sciences industry.

About iSpecimen

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.

HQ: Woburn, MA7 employeesListed Jun 17, 2021ispecimen.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology